Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Clinical trial NCT05789056 · RECRUITING
Trial details
- NCT number
- NCT05789056
- Sponsor
- Quoin Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-14
- Primary completion
- 2025-12-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.